This blog is related to the various litigations related to patents w.r.t pharma industry.
Tuesday, July 29, 2008
UCB Receives Not-Approvable Letter from FDA for Lacosamide for Diabetic Neuropathic Pain
July 29, 2008--UCB announced today that it received a not-approvable letter from the U.S. Food and Drug Administration (FDA) for lacosamide for the treatment of diabetic neuropathic pain in adults.
No comments:
Post a Comment